<DOC>
	<DOCNO>NCT02131805</DOCNO>
	<brief_summary>The purpose study assess effectiveness electronic skin surface brachytherapy ( ESSB ) early stage basal squamous cell carcinoma skin use new device . This new device Nucletron 's Esteya Electronic Skin Surface Brachytherapy System . The investigator want understand effect , good and/or bad device deliver brachytherapy skin cancer . The investigator also want assess safety , cosmetic result , effect ESSB quality life correlate skin image clinical response ESSB .</brief_summary>
	<brief_title>Electronic Skin Surface Brachytherapy Cutaneous Basal Cell Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<criteria>Men woman ≥ 60 year old estimate life expectancy ≥ 5 year Histopathologic diagnosis basal squamous cell carcinoma Clinical stage T1N0M0 ( AJCC 2010 criterion ) °Basal cell carcinoma morpheaform , sclerosing , mixed , infiltrative micronodular feature must ≤1 cm Low risk pathologic feature ( AJCC 2010 criterion ) Eastern Cooperative Oncology Group ( ECOG ) performance status 03 ( Appendix C ) Able willing complete Skindex16 Skin Cancer Index ( must able speak English ) Ability provide inform consent BCC/SCC previously treat ( ie , recurrent BCC/SCC ) BCC/SCC region adjacent overlap region prior radiotherapy BCC/SCC irregular surface ( ie , target area flat ) BCC/SCC adjacent overlap burn scar BCC/SCC area prone trauma ( include , limited skin overlie tibia , dorsum hand elbow ) BCC/SCC area compromise lymphatic drainage vascular supply BCC/SCC within 3 cm another treat untreated BCC/SCC Inflammatory process target area Collagen vascular disease ( lupus , scleroderma , rheumatoid arthritis ) Diabetes poorly control Genetic disorder predispose patient skin cancer radiation sensitivity ( basal cell nevus syndrome , xeroderma pigmentosum , ataxia telangiectasia mutans ) Receipt treatment another investigational device drug Receipt drug affect biologic response radiation ( radiosensitizer radioprotector ) High likelihood protocol noncompliance ( opinion investigator )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>skin</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>14-001</keyword>
</DOC>